Effects of Individual Physician-Level and Practice-Level Financial Incentives on Hypertension Care
Open Access
- 11 September 2013
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 310 (10), 1042-1050
- https://doi.org/10.1001/jama.2013.276303
Abstract
As part of the Affordable Care Act, the US government has introduced pay for performance to all hospitals paid by Medicare nationwide.1 The New York City Health and Hospitals Corporation recently announced a performance pay plan for physicians.2 These and other value-based purchasing systems are intended to align incentives to promote high-quality health care.3 Evaluations of the effectiveness of pay-for-performance programs directed at hospitals have shown contradictory results.3-5 The Premier Hospital Quality Incentive Demonstration showed an increase of up to 4.1 percentage points in process-quality measures during the first 2 years,6 but these modest gains were not sustained.7 Moreover, risk-adjusted mortality in the same program showed no improvement.8This publication has 26 references indexed in Scilit:
- Does Performance-Based Remuneration for Individual Health Care Practitioners Affect Patient Care?Annals of Internal Medicine, 2012
- Financial incentives and physician commitment to guideline-recommended hypertension management.2012
- A behavioral model of clinician responses to incentives to improve qualityHealth Policy, 2007
- Does Pay-for-Performance Improve the Quality of Health Care?Annals of Internal Medicine, 2006
- Overcome Clinical Inertia to Control Systolic Blood PressureArchives of Internal Medicine, 2003
- Building a Better Quality MeasureMedical Care, 2003
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 ReportJAMA, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Statistical considerations in the design and analysis of community intervention trialsJournal of Clinical Epidemiology, 1996
- Introduction to sample size determination and power analysis for clinical trialsControlled Clinical Trials, 1981